Quick Takeaways
- ARMISTICE CAPITAL, LLC filed SCHEDULE 13G/A for TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value (RANI).
- Disclosed ownership: 9.9%.
- Date of event: 30 Jun 2025.
ARMISTICE CAPITAL, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value (RANI)
- Filing Manager
- ARMISTICE CAPITAL, LLC
- Reporting Manager
- Armistice Capital, LLC
- Symbol
- RANI
- Shares outstanding
- 63,168,517 shares
- Disclosed Ownership
- 6,260,000 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 Aug 2025, 12:29:16 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ARMISTICE CAPITAL, LLC disclosed 9.9% ownership in TREACE MEDICAL CONCEPTS, INC. Common stock, $0.001 par value (RANI) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Aug 2025, 12:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Armistice Capital, LLC | 9.9% | 6,260,000 | 0 | 6,260,000 | /s/ Steven Boyd | Steven Boyd - Managing Member | |
| Steven Boyd | 9.9% | 6,260,000 | 0 | 6,260,000 | /s/ Steven Boyd | Steven Boyd |